Neuropathological stageing of Alzheimer-related changes

1991/09/01 by H. Braak, Heiko Braak, E. Braak +1 · 173 citations
Medicine · Neuroscience · #Alzheimer's disease research and treatments #Dementia and Cognitive Impairment Research #Memory and Neural Mechanisms

paper · doi:10.1007/bf00308809

Cited by

• Synaptic degeneration in Alzheimer’s disease
• Distribution patterns of tau pathology in progressive supranuclear palsy
• Roles of tau protein in health and disease
• National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
• Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts
• Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy
• The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome
• Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
• Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neurons
• Necrosome complex detected in granulovacuolar degeneration is associated with neuronal loss in Alzheimer’s disease
• Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia
• APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer’s disease with Lewy body pathology
• The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease
• Regulated cell death and its role in Alzheimer’s disease and amyotrophic lateral sclerosis
• Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions
• Mothering a Female Saint: Susan Warner's Dialogic Role in 'The Wide, Wide World.'
• Sex Differences in the Clinical Manifestations of Alzheimer Disease Pathology
• Prediction of Dementia by Subjective Memory Impairment<subtitle>Effects of Severity and Temporal Association With Cognitive Impairment</subtitle><alt-title>Dementia and Subjective Memory Impairment</alt-title>
• Regional Distribution of Neurofibrillary Tangles and Senile Plaques in the Cerebral Cortex of Very Old Patients
• Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment
• Conformational Changes Specific for Pseudophosphorylation at Serine 262 Selectively Impair Binding of Tau to Microtubules
• Clinical and diagnostic implications of Alzheimer's disease copathology in Lewy body disease
• Distinct transcriptional alterations distinguish Lewy body disease from Alzheimer’s disease
• Age impairs mnemonic discrimination of objects more than scenes: A web-based, large-scale approach across the lifespan
• Amyloid assembly and disassembly
• <scp>DSCR1</scp> upregulation enhances dural meningeal lymphatic drainage to attenuate amyloid pathology of <scp>A</scp>lzheimer's disease
• Improved Detection of Substantia Nigra Pathology in Alzheimer's Disease
• Axonal pathology in traumatic brain injury
• Plaques, Tangles, and Memory Loss in Mouse Models of Neurodegeneration
• Molecular pathology of neurodegenerative diseases: principles and practice
• The human entorhinal cortex: A cytoarchitectonic analysis
• Assessing individual variability of the entorhinal subfields in health and disease
• Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI
• Microglial Activation parallels System Degeneration in progressive Supranuclear palsy and Corticobasal Degeneration
• Mild cognitive impairment and on to dementia
• Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005–2010
• Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
• Neuropathology of Cognitively Normal Elderly
• Morphogenesis of Lewy Bodies: Dissimilar Incorporation of α-Synuclein, Ubiquitin, and p62
• Visual Association Pathology in Preclinical Alzheimer Disease
• Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition
• The intricate role of CCL5/CCR5 axis in Alzheimer disease
• Cerebral Small Vessel Disease-Induced Apolipoprotein E Leakage Is Associated With Alzheimer Disease and the Accumulation of Amyloid β-Protein in Perivascular Astrocytes
• Characteristics of Dyshoric Capillary Cerebral Amyloid Angiopathy
• Hemispheric Asymmetry and Atypical Lobar Progression of Alzheimer-Type Tauopathy
• Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies
• Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography
• 7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature
• Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
• The Revised National Alzheimer’s Coordinating Center’s Neuropathology Form—Available Data and New Analyses
• The Amygdala as a Locus of Pathologic Misfolding in Neurodegenerative Diseases
• Vascular Lesions, <i>APOE</i> ε4, and Tau Pathology in Alzheimer Disease
• Integrated multimodal cell atlas of Alzheimer’s disease
• Chronic pain in Alzheimer disease and the role of neuroimmune interactions
• Vision function abnormalities in Alzheimer disease
• Alpha synuclein co-pathology is associated with accelerated amyloid-driven tau accumulation in Alzheimer’s disease
• Hippocampal GABAergic Inhibitory Interneurons
• The Microbiota-Gut-Brain Axis
• Impaired perceptual discrimination of complex objects in older adults at risk for dementia
• Spatial proteomic differences in chronic traumatic encephalopathy, Alzheimer's disease, and primary age‐related tauopathy hippocampi
• Amyloid-β and tau deposition in traumatic brain injury: a study of Vietnam War veterans
• Comparison of histological delineations of medial temporal lobe cortices by four independent neuroanatomy laboratories
• MCR-VQGAN: A Scalable and Cost-Effective Tau PET Synthesis Approach for Alzheimer's Disease Imaging
• Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
• Detecting Discontinuities in the Topology of Alzheimers gene Co-expression
• Longitudinal Evaluation of ¹⁸ F-MK-6240 Along the Alzheimer Disease Continuum
• Entorhinal cortex dysfunction in Alzheimer's disease
• The multiple roles of chronic stress and glucocorticoids in Alzheimer's disease pathogenesis
• Phosphorylated tau aggregation in the brains of aged Artiodactyla animals
• Optimal stimulation sites are not the most affected: personalised models of resting-state fMRI in Alzheimer's disease
• Microglia aggregates define distinct immune and neurodegenerative niches in Alzheimer's disease hippocampus
• The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease
• Hemispheric asymmetry of tau pathology is related to asymmetric amyloid deposition in Alzheimer’s Disease
• Krüppel-like Factor 8 Ameliorates Alzheimer's Disease by Activating β-Catenin
• Calcium signaling in individual APP/PS1 mouse dentate gyrus astrocytes increases <i>ex vivo</i> with Aβ pathology and age without affecting astrocyte network activity
• Abnormal TDP-43 expression is identified in the neocortex in cases of dementia pugilistica, but is mainly confined to the limbic system when identified in high and moderate stages of Alzheimer's disease
• <scp>A</scp>rizona <scp>S</scp>tudy of <scp>A</scp>ging and <scp>N</scp>eurodegenerative <scp>D</scp>isorders and <scp>B</scp>rain and <scp>B</scp>ody <scp>D</scp>onation <scp>P</scp>rogram
• Aging and Alzheimer's disease pathology
• Corticobasal degeneration with visual hallucination as an initial symptom: A case report
• La patria como tema y sus variaciones en tres poemarios representativos de Lucía Muñoz Maceo
• Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference
• Pattern separation and pattern completion in Alzheimer's disease: Evidence of rapid forgetting in amnestic mild cognitive impairment
• Reactive astrocytes in Alzheimer’s disease: A double-edged sword
• A cognitive–motor framework for spatial navigation in aging and early-stage Alzheimer's disease
• Elevated locus coeruleus metabolism provides resilience against cognitive decline in preclinical Alzheimer's disease
• Cortical gray–white matter contrast alterations precede amyloid‐β positivity and macrostructural changes in older adults without dementia
• Smartphone-based detection of subtle memory decline in prodromal Alzheimer’s disease
• Molecular Dynamics Study of the Binding of Cationic, Anionic, and Neutral Luminescent Conjugated Ligands to the Alzheimer Folds of A <i>β</i> (1–42) and Tau Fibrils
• The measurement of everyday cognition (ECog): Scale development and psychometric properties.
• Brain volume change and cognitive trajectories in aging.
• Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory
• Genetic convergence in brain aging and neurodegeneration: from cellular mechanisms to therapeutic targets
• Reconstructing Subject-Specific Effect Maps
• A systematic comparison of ATN biomarkers for monitoring longitudinal cognitive changes in Alzheimer's disease
• <scp>3D</scp> imaging of neuronal inclusions and protein aggregates in human neurodegeneration by multiscale x‐ray phase‐contrast tomography
• Cognitive and neuropsychological trajectories in patients with mixed neurodegenerative pathologies
• Neural Metabolic Networks: Key Elements of Healthy Brain Function
• Alzheimer's disease is a laminar, regional, and neural system specific disease, not a global brain disease
• S-Chain: Structured Visual Chain-of-Thought For Medicine
• Understanding Mechanistic Role of Structural and Functional Connectivity in Tau Propagation Through Multi-Layer Modeling
• Structural imaging of hippocampal subfields in healthy aging and Alzheimer’s disease
• Sex differences for regional pathology in people with a high likelihood of Lewy body dementia phenotype based on underlying pathology
• pTau pathology in the retina of TAU58 mice: association with ganglion cell degeneration and implications on seeding and propagation of pTau from human brain lysates
• Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity
• Endothelial Cells Are Heterogeneous in Different Brain Regions and Are Dramatically Altered in Alzheimer's Disease
• Staging of brain pathology related to sporadic Parkinson’s disease
• Reserve, resilience and maintenance of episodic memory and other cognitive functions in aging
• Disentangling Neurodegeneration with Brain Age Gap Prediction Models: A Graph Signal Processing Perspective
• Tau, atrophy, and domain‐specific cognitive impairment in typical Alzheimer's disease
• Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies known and novel cross-population and ancestry-specific associations as novel risk loci for Alzheimer’s disease
• Developing a novel reference region for [18F]PI-2620-PET imaging to facilitate the assessment of 4-repeat tauopathies
• Late-onset unexplained seizures are associated with cognitive impairment and lower amygdala volumes
• Tau filaments are tethered within brain extracellular vesicles in Alzheimer’s disease
• Deep learning reveals pathology-confirmed neuroimaging signatures in Alzheimer’s, vascular and Lewy body dementias
• Synaptic gene expression changes in frontotemporal dementia due to the <i>MAPT</i> 10 + 16 mutation
• Automated Imaging Differentiation for Dementia
• Selective reduction of ADAM10 in brain and cerebrospinal fluid of Alzheimer’s disease patients
• Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline
• Quantification of Protein Secondary Structures from Discrete Frequency Infrared Images Using Machine Learning
• Plasma p-tau217 and glucose metabolism correlate in neocortical association areas in Alzheimer's disease
• Tau Protein Squired by Molecular Chaperones During Alzheimer’s Disease
• Automated bimodal pause analysis for acoustic markers of cognitive decline and Alzheimer's disease in connected speech
• Modifiable risk factor profiles moderate the effect of β-amyloid pathology on cognition in aging
• Biological age acceleration in Alzheimer’s disease modulates relative cortical to medial temporal lobe neurodegeneration
• Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillations
• Primary retinal tauopathy: A tauopathy with a distinct molecular pattern
• Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer’s Disease
• Depth- and curvature-based quantitative susceptibility mapping analyses of cortical iron in Alzheimer’s disease
• Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer’s disease neuropathology
• Synaptic density and tau pathology in Alzheimer’s disease: a dual role in susceptibility and degeneration
• Maintaining and regaining episodic memory in Alzheimer disease: a circuit-based perspective
• Degeneration in Nucleus basalis of Meynert signals earliest stage of Alzheimer’s disease progression
• Multivariate MR Biomarkers Better Predict Cognitive Dysfunction in Mouse\n Models of Alzheimers Disease
• Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
• Self-Supervised Cross-Encoder for Neurodegenerative Disease Diagnosis
• Network Models of Neurodegeneration: Bridging Neuronal Dynamics and Disease Progression
• TauGenNet: Plasma-Driven Tau PET Image Synthesis via Text-Guided 3D Diffusion Models
• Latent space projections and atlases: A cautionary tale in deep neuroimaging using autoencoders
• The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias
• Combined Connectomics, <scp><i>MAPT</i></scp> Gene Expression, and Amyloid Deposition to Explain Regional Tau Deposition in Alzheimer Disease
• Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex
• Network-guided analysis of hippocampal proteome identifies novel proteins that colocalize with Aβ in a mice model of early-stage Alzheimer’s disease
• EEG-MSAF: An Interpretable Microstate Framework uncovers Default-Mode Decoherence in Early Neurodegeneration
• α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects
• Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy
• The effect of Alzheimer’s biomarker positivity on neuropsychological networks
• A complex network perspective on brain disease
• Eva Braak [wikipedia]
• Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. [europepmc]
• Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. [europepmc]
• Neurodegenerative diseases target large-scale human brain networks. [europepmc]
• Transmission and spreading of tauopathy in transgenic mouse brain. [europepmc]
• Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. [europepmc]
• The clinical use of structural MRI in Alzheimer disease. [europepmc]
• Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. [europepmc]
• Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. [europepmc]
• National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. [europepmc]
• National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. [europepmc]
• Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. [europepmc]
• Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. [europepmc]
• Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. [europepmc]
• Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. [europepmc]
• Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. [europepmc]
• Primary age-related tauopathy (PART): a common pathology associated with human aging. [europepmc]
• Depletion of microglia and inhibition of exosome synthesis halt tau propagation. [europepmc]
• Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. [europepmc]
• Single-cell transcriptomic analysis of Alzheimer's disease. [europepmc]
• The neuropathological diagnosis of Alzheimer's disease. [europepmc]
• Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. [europepmc]
• Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. [europepmc]
• Alzheimer disease. [europepmc]
• Inflammation in obesity, diabetes, and related disorders. [europepmc]
• Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. [europepmc]